Sfoglia per AUTORE
CORTELEZZI A
Collezione AOU Novara

  

Items : 15

Biological and clinical implications of BIRC3 mutations in chronic lymphocytic leukemia. in Haematologica / Haematologica. 2020 Jan 31;105(2):448-456. doi: 10.3324/haematol.2019.219550. Print 2020.
2020
AOU Città della Salute di Torino
AOU Novara

Rossi D; Gaidano G; Foà R; Deaglio S; Catherwood M; Boldorini RL; Gattei V; Cuneo A; Follenzi A; Poeta GD; Bertoni F; Lawless S; Thornton P; Mills K; Donaldson D; Weir P; Motta M; Laurenti L; Tedeschi A; Perbellini O; Coscia M; Marasca R; Rigolin GM; Chiarenza A; Visco C; Rossi FM; Bomben R; Cortelezzi A; Zaja F; et alii...

Use of eltrombopag in aplastic anemia in Europe. in Annals of hematology / Ann Hematol. 2019 Jun;98(6):1341-1350. doi: 10.1007/s00277-019-03652-8. Epub 2019 Mar 26.
2019
AOU Novara

Maschan A; Dreger P; Eikema DJ; Afanasyev B; Lengline É; Knol-Bout C; Bosman P; Ecsedi M; Halkes CJM; Drexler B; Cortelezzi A; Drénou B; Patriarca A; Bruno B; Onofrillo D; Lanino E; Pulanic D; Serventi-Seiwerth R; Garnier A; Ljungman P; Bonifazi F; Giammarco S; Tournilhac O; Pioltelli P; Rovó A; Risitano AM; de Latour RP; Dufour C; Passweg J; et alii...

Predictors of refractoriness to therapy and healthcare resource utilization in 378 patients with primary autoimmune hemolytic anemia from eight Italian reference centers. in American journal of hematology / Am J Hematol. 2018 Sep;93(9):E243-E246. doi: 10.1002/ajh.25212. Epub 2018 Aug 25.
2018
AOU Novara

Barcellini W; Zaninoni A; Fattizzo B; Giannotta JA; Lunghi M; Ferrari A; Leporace AP; Maschio N; Scaramucci L; Cantoni S; Chiurazzi F; Consonni D; Rossi G; De Fabritiis P; Gaidano G; Zanella A; Cortelezzi A;

2018
AOU Novara

Morabito F; Shanafelt TD; Gentile M; Reda G; Mauro FR; Rossi D; Di Renzo N; Molica S; Angrilli F; Chiarenza A; Cutrona G; Chaffee KG; Parikh SA; Tripepi G; D'Arrigo G; Vigna E; Recchia AG; Cortelezzi A; Gaidano G; Di Raimondo F; Fais F; Foà R; Neri A; Ferrarini M;

Predictive value of the CLL-IPI in CLL patients receiving chemo-immunotherapy as first-line treatment. in European journal of haematology / Eur J Haematol. 2018 Jul 24. doi: 10.1111/ejh.13149.
2018
AOU Città della Salute di Torino
AOU Novara

Morabito F; Foà R; Polliack A; Kay NE; Gaidano G; Ferrarini M; Neri A; Cortelezzi A; Del Poeta G; Di Raimondo F; Recchia AG; Innocenti I; Shvidel L; Zirlik K; Vigna E; Sameer PA; Chaffee KG; Tripepi G; Bairey O; Rago A; Giordano A; Angrilli F; Ciolli S; Goldschmidt N; Molica S; Chiarenza A; Herishanu Y; Coscia M; Angeletti I; et alii...

2018
ASL Asti
AOU Città della Salute di Torino
AOU Novara

Ghia P; Moreno C; Foà R; de la Serna J; Vignetti M; Kennedy B; Bowles KM; Eyre TA; Schuh A; Smolej L; Montillo M; Cortelezzi A; Ciolli S; Forconi F; Gonzalez M; Gaidano G; Re F; Molica S; Marchetti M; Ilariucci F; Meneghini V; Chiarenza A; Marasca R; Billio A; Visco C; Amendola A; Mauro FR; Galieni P; Orlandi EM; et alii...

Validation of a biological score to predict response in chronic lymphocytic leukemia patients treated front-line with bendamustine and rituximab. in Leukemia / Leukemia. 2018 Aug;32(8):1869-1873. doi: 10.1038/s41375-018-0100-6. Epub 2018 Mar 20.
2018
AOU Città della Salute di Torino
AOU Novara

Morabito F; Polliack A; Foà R; Ferrarini M; Neri A; Di Raimondo F; Gaidano G; Del Poeta G; Cortelezzi A; Tadmor T; Shvidel L; Herishanu Y; Recchia AG; Vigna E; D'Arrigo G; Tripepi G; Innocenti I; Uccello G; Parikh SA; Chaffee KG; Cutrona G; Giordano A; Chiarenza A; Coscia M; Angrilli F; Molica S; Di Renzo N; Rossi D; Del Principe MI; et alii...

Unbiased pro-thrombotic features at diagnosis in 977 thrombocythemic patients with Philadelphia-negative chronic myeloproliferative neoplasms. in Leukemia research / Leuk Res. 2016 Jul;46:18-25. doi: 10.1016/j.leukres.2016.04.004. Epub 2016 Apr 7.
2016
AOU Novara

Gugliotta L; Iurlo A; Gugliotta G; Tieghi A; Specchia G; Gaidano G; Scalzulli PR; Rumi E; Dragani A; Martinelli V; Santoro C; Randi ML; Tagariello G; Candoni A; Cattaneo D; Ricco A; Palmieri R; Liberati MA; Langella M; Rago A; Bergamaschi M; Monari P; Miglio R; Santoro U; Cacciola R; Rupoli S; Mastrullo L; Musto P; Mazzucconi MG; et alii...

Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia. in Blood / Blood. 2015 Oct 15;126(16):1921-4. doi: 10.1182/blood-2015-05-647925. Epub 2015 Aug 14.
2015
AO Ordine Mauriziano
AOU Città della Salute di Torino
AOU Novara

Gaidano G; Gattei V; Foà R; Cuneo A; Montillo M; Massaia M; Zinzani PL; Del Poeta G; Perbellini O; Moreno C; Marasca R; Tedeschi A; Neri A; Motta M; Coscia M; Rigolin GM; Vincelli I; Del Giudice I; Gentile M; Laurenti L; Forconi F; Zaja F; Morabito F; Cortelezzi A; Mauro FR; Visco C; Chiarenza A; Bulian P; Ghilardi G; et alii...

Low-dose alemtuzumab in refractory/relapsed chronic lymphocytic leukemia: Genetic profile and long-term outcome from a single center experience. in American journal of hematology / Am J Hematol. 2015 Nov;90(11):970-4. doi: 10.1002/ajh.24127. Epub 2015 Aug 14.
2015
AOU Novara

Sciumè M; Vincenti D; Reda G; Orofino N; Cassin R; Giannarelli D; Gaidano G; Rossi D; Cortelezzi A;

A phase II multi-center trial of pentostatin plus cyclophosphamide with ofatumumab in older previously untreated chronic lymphocytic leukemia patients. in Haematologica / Haematologica. 2015 Dec;100(12):e501-4. doi: 10.3324/haematol.2015.132035. Epub 2015 Aug 20.
2015
AOU Città della Salute di Torino
AOU Novara

Rambaldi A; Orlandi E; Picardi P; De Paoli L; Dalceggio D; Frustaci AM; Cairoli R; Scarfò L; Nador G; Cortelezzi A; Rossini F; Anastasia A; Coscia M; Rossi M; Quaresmini G; Motta M; Rossi D; Tedeschi A; Massaia M; Gaidano G; Montillo M;

Association between gene and miRNA expression profiles and stereotyped subset #4 B-cell receptor in chronic lymphocytic leukemia. in Leukemia & lymphoma / Leuk Lymphoma. 2015;56(11):3150-8. doi: 10.3109/10428194.2015.1028051. Epub 2015 May 18.
2015
AOU Novara

Maura F; Cutrona G; Mosca L; Matis S; Lionetti M; Fabris S; Agnelli L; Colombo M; Massucco C; Ferracin M; Zagatti B; Reverberi D; Gentile M; Recchia AG; Bossio S; Rossi D; Gaidano G; Molica S; Cortelezzi A; Di Raimondo F; Negrini M; Tassone P; Morabito F; Ferrarini M; Neri A;

Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: a GIMEMA study of 308 patients. in Blood / Blood. 2014 Nov 6;124(19):2930-6. doi: 10.1182/blood-2014-06-583021. Epub 2014 Sep 16.
2014
AOU Novara

Barcellini W; Fattizzo B; Zaninoni A; Radice T; Nichele I; Di Bona E; Lunghi M; Tassinari C; Alfinito F; Ferrari A; Leporace AP; Niscola P; Carpenedo M; Boschetti C; Revelli N; Villa MA; Consonni D; Scaramucci L; De Fabritiis P; Tagariello G; Gaidano G; Rodeghiero F; Cortelezzi A; Zanella A;

Bendamustine in combination with ofatumumab in relapsed or refractory chronic lymphocytic leukemia: a GIMEMA Multicenter Phase II Trial. in Leukemia / Leukemia. 2014 Mar;28(3):642-8. doi: 10.1038/leu.2013.334. Epub 2013 Nov 13.
2014
AOU Novara

Cortelezzi A; Sciumè M; Liberati AM; Vincenti D; Cuneo A; Reda G; Laurenti L; Zaja F; Marasca R; Chiarenza A; Gritti G; Orsucci L; Storti S; Angelucci E; Cascavilla N; Gobbi M; Mauro FR; Morabito F; Fabris S; Piciocchi A; Vignetti M; Neri A; Rossi D; Giannarelli D; Guarini A; Foà R;

Clinical monoclonal B lymphocytosis versus Rai 0 chronic lymphocytic leukemia: A comparison of cellular, cytogenetic, molecular, and clinical features. in Clinical cancer research : an official journal of the American Association for Cancer Research / Clin Cancer Res. 2013 Nov 1;19(21):5890-900. doi: 10.1158/1078-0432.CCR-13-0622. Epub 2013 Sep 13.
2013
AOU Novara

Massucco C; Recchia AG; Lionetti M; Fabris S; Maura F; Matis S; Gentile M; Vigna E; Cutrona G; Agnelli L; Tuana G; Ferracin M; Zagatti B; Mosca L; Morabito F; Colombo M; Bossio S; De Stefano L; Ilariucci F; Musolino C; Molica S; Di Raimondo F; Cortelezzi A; Tassone P; Negrini M; Monti S; Rossi D; Gaidano G; Ferrarini M; et alii...